Disease recurrence in paediatric renal transplantation

Pediatric Nephrology

Volumn 24, Issue 11, 2009, Pages 2097-2108

  Cochat, Pierre ^a   Fargue, Sonia ^b   Mestrallet, Guillaume ^a   Jungraithmayr, Therese ^c   Koch Nogueira, Paulo ^d   Ranchin, Bruno ^a   Zimmerhackl, Lothar Bernd ^c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Child; Disease recurrence; Focal and segmental glomerulosclerosis; Haemolytic uraemic syndrome; Membranoproliferative glomerulonephritis; Primary hyperoxaluria type 1; Renal transplantation; Systemic lupus erythematosus

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FRESH FROZEN PLASMA; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ALPORT SYNDROME; ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; CANCER RISK; CONTINUOUS INFUSION; CYSTINOSIS; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG MEGADOSE; ENZYME DEFICIENCY; FABRY DISEASE; FOCAL GLOMERULOSCLEROSIS; GENETIC PREDISPOSITION; GLOMERULOPATHY; GOODPASTURE SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN A NEPHROPATHY; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; LIPOPROTEIN GLOMERULOPATHY; LOWER URINARY TRACT SYMPTOM; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE 1; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE 2; MEMBRANOUS GLOMERULONEPHRITIS; METHYLMALONIC ACIDEMIA; NEPHROTIC SYNDROME; NEPHROTOXICITY; NONHUMAN; OXALOSIS 1; PATHOPHYSIOLOGY; PEDIATRIC SURGERY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RECURRENCE RISK; RECURRENT DISEASE; RENAL GRAFT DYSFUNCTION; REVIEW; SARCOIDOSIS; SICKLE CELL ANEMIA; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; UNSPECIFIED SIDE EFFECT;

CHILD; CHILD, PRESCHOOL; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYPEROXALURIA, PRIMARY; INCIDENCE; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECURRENCE; RISK FACTORS;

EID: 70349756975     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1137-6     Document Type: Review

References (82)

1. Seikaly MG (2004) Recurrence of primary disease in children after renal transplantation: An evidence-based update. Pediatr Transplant 8:113-119
2. North American Pediatric Renal Trials and Collaborative Studies (2007) Report. Available at https://web.emmes.com/study/ped/annlrept/ annlrept.html
3. Hariharan S, Savin V (2004) Recurrent and de novo disease after renal transplantation: A report from the renal allograft disease registry. Pediatr Transplant 8:349-350
4. Baqi N, Tejani A (1997) Recurrence of original disease in pediatric renal transplant. J Nephrol 10:85-92
5. Loirat C, Niaudet P (2003) The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 18:1095-1101
6. Loirat C, Fremeaux-Bacchi V (2008) Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transplant 12:619-629
7. Ferraris JR, Ramirez JA, Ruiz S, Caletti MG, Vallejo G, Piantanida JJ, Araujo JL, Sojo ET (2002) Shiga toxin-associated hemolytic uremic syndrome: Absence of recurrence after renal transplantation. Pediatr Nephrol 17:809-814
8. Zimmerhackl LB, Scheiring J, Prüfer F, Taylor M, Loirat C (2007) Renal transplantation in HUS patients with disorders of complement regulation. Pediatr Nephrol 22:10-16
9. Moroni G, Tantardini F, Gallelli B, Quaglini S, Banfi G, Poli F, Montagnino G, Meroni P, Messa P, Ponticelli C (2005) The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis 45:903-911
10. Lien YH, Scott K (2000) Long-term cyclophosphamide treatment for recurrent type 1 membranoproliferative glomerulonephritis after transplantation. Am J Kidney Dis 35:539-543
11. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A (2001) Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 60:1948-1954
12. Ibrahim H, Rogers T, Casingal V, Sturdevant M, Tan M, Humar A, Gillingham K, Matas A (2006) Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation 81:214-219
13. Newstead CG (2003) Recurrent disease in renal transplant. Nephrol Dial Transplant 18:68-74
14. Cochat P, Fargue S, Liutkus A, Ranchin B (2006) Récidive du syndrome néphrotique après transplantation rénale. Courr Transplant 6:154-160
15. Salmon AHJ, Kamel D, Mathieson PW (2004) Recurrence of IgM nephropathy in a renal allograft. Nephrol Dial Transplant 19:2650-2652
16. Benchimol C (2003) Focal segmental glomerulosclerosis: Pathogenesis and treatment. Curr Opin Pediatr 15:171-180
17. Weber S, Tönshoff B (2005) Recurrence of focal segmental glomerulosclerosis in children after renal transplantation: Clinical and genetic aspects. Transplantation 80 (Suppl 1):S128-S134
18. Reidy K, Kaskel FJ (2007) Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol 22:350-354
19. Jungraithmayr T, Cochat P, Fargue S, Hofer K, Knueppel T, Cortina G, Neuhaus T, Seeman T, Tönshoff B, Winn MP, Zimmerhackl LB, for the ECoFTS (2007) Role of NPHS2 and TRPC6 in recurring focal segmental glomerulosclerosis: Results from the European Collaborative FSGS Transplantation Study. J Am Soc Nephrol 18:SU-FC121
20. Fujisawa M, Iijima K, Ishimura T, Higuchi A, Isotani S, Yoshiya K, Arakawa S, Hamami G, Matsumoto O, Yoshikawa N, Kamidono S (2002) Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation. Pediatr Nephrol 17:165-168
21. Baum MA, Ho M, Stablein DM, Alexander SR, North American Pediatric Renal Transplant Cooperative Study (2002) Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr Transplant 6:488-492
22. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP (1994) Effect of plasma protein adsorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7-14
23. Cochat P, Kassir A, Colon S, Glastre C, Tourniaire B, Parchoux B, Martin X, David L (1993) Recurrent nephrotic syndrome after transplantation: early treatment with plasmapheresis and cyclophosphamide. Pediatr Nephrol 7:50-54
24. Raafat R, Travis L, Kalia A, Diven S (2000) Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatr Nephrol 14:189-194
25. Salomon R, Gagnadoux MF, Niaudet P (2003) Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 27:810-814
26. Ahmed MS, Wong CF (2008) Rituximab and nephrotic syndrome: A new therapeutic hope? Nephrol Dial Transplant 23:11-17
27. Westphal S, Hansson S, Mjörnstedt L, Mölne J, Swerkersson S, Friman S (2006) Early recurrence of nephrotic syndrome after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulins and rituximab. Transplant Proc 38:2659-2660
28. Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M (2005) Rituximab treatment for posttransplant lymphoproliferative disorder induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 20:1660-1663
29. Pescovitz MD, Book BK, Sidner RA (2006) Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 354:1961-1963
30. Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M (2008) Rituximab for post-transplant recurrences of FSGS. Pediatr Transplant doi: 10.1111/j.1399-3046.2008.00967.x
31. Marks SD, McGraw M (2007) Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation? Pediatr Nephrol 22:158-160
32. Gohh RY, Yango AF, Morissey PE, Monaco AP, Gautam A, Sharma M, McCarthy ET, Savin VJ (2005) Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 5:2907-2912
33. Quan A, Sullivan EK, Alexander SR (2001) Recurrence of hemolytic uremic syndrome after renal transplantation in children. Transplantation 72:742-744
34. Tsai HM (2006) The molecular biology of thrombotic microangiopathy. Kidney Int 70:16-23
35. Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship THJ, Remuzzi G, for the International Registry of Recurrent and Familial HUS/TTP (2006) Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: Prognostic significance of genetic background. Clin J Am Soc Nephrol 1:88-99
36. Remuzzi G, Ruggenenti P, Codazzi D, Noris M, Caprioli J, Locatelli G, Gridelli B (2002) Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 359:1671-1672
37. Jalanko H, Peltonen S, Koskinen A, Puntila J, Isoniemi H, Holmberg C, Pinomäki A, Armstrong E, Koivusalo A, Mäkisalo H, Saland J, Remuzzi G, de Cordoba S, Lassila R, Meri S, Jokiranta TS (2008) Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant 8:216-221
38. Cameron JS (1982) Glomerulonephritis in renal transplants. Transplantation 34:237-245
39. Gagnadoux MF, Niaudet P, Broyer M (1993) Non-immunological risk factors in pediatric renal transplantation. Pediatr Nephrol 7:89-95
40. Andresdottir MB, Assmann KJM, Hilbrands LB, Wetzels JFM (2000) Primary Epstein-Barr virus infection and recurrent type I membrano-proliferative glomerulonephritis after renal transplantation. Nephrol Dial Transplant 15:1235-1237
41. Saxena R, Frankel WL, Sedmak DD, Falkenhain ME, Cosio FG (2000) Recurrent type 1 membranoproliferative glomerulonephritis in a renal allograft: Successful treatment with plasmapheresis. Am J Kidney Dis 35:749-752
42. Braun MC, Stablein DM, Hamiwka LA, Bell L, Bartosh SM, Strife CF (2005) Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study Group. J Am Soc Nephrol 16:2225-2233
43. Cosyns JP, Couchoud C, Pouteil-Noble C, Squifflet JP, Pirson Y (1998) Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol 50:144-153
44. Andrews PA (1999) Lipoprotein glomerulopathy: A new cause of nephrotic syndrome after renal transplantation. Implications for renal transplantation. Nephrol Dial Transplant 14:239-240
45. Cochat P, Liutkus A, Fargue S, Basmaison O, Ranchin B, Rolland MO (2006) Primary hyperoxaluria type 1: Still challenging! Pediatr Nephrol 21:1075-1081
46. Lorenzo V, Alvarez A, Torres A, Torregrosa V, Hernandez D, Salido E (2006) Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: Single-center experience. Kidney Int 70:1115-1119
47. van Woerden CS, Groothoff JW, Wijburg FA, Annink C, Wanders RJ, Waterham HR (2004) Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 66:746-752
48. Beck BB, Hoppe B (2006) Is there a genotype-phenotype correlation in primary hyperoxaluria type 1? Kidney Int 70:984-986
49. Floege J, Burg M, Kliem V (1998) Recurrent IgA nephropathy after kidney transplantation: Not a benign condition. Nephrol Dial Transplant 13:1933-1935
50. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG (1998) Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 65:1053-1060
51. Chandrakantan A, Ratanapanichkich P, Said M, Barker CV, Julian BA (2005) Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil. Nephrol Dial Transplant 20:1214-1221
52. Broyer M, Selwood N, Brunner F (1992) Recurrence of primary renal disease on kidney graft: European pediatric experience. J Am Soc Nephrol 2:S255-S257
53. Hasegawa A, Kawamura T, Ito H, Hasegawa O, Ogawa O, Honda M, Ohara T, Hajikano H (1989) Fate of renal grafts with recurrent Henoch-Schönlein purpura nephritis in children. Transplant Proc 21:651-656
54. Meulders Q, Pirson Y, Cosyns JP, Squifflet JP, van Ypersele de Strihou C (1994) Course of Henoch-Schönlein nephritis after renal transplantation. Transplantation 48:1179-1186
55. Briggs JD, Jones E, on behalf of the scientific advisory board of the ERA-EDTA registry (1999) Renal transplantation for uncommon diseases. Nephrol Dial Transplant 14:570-575
56. Goral S, Ynares C, Schappell SB, Snyder S, Feurer ID, Kazancioglu R, Fogo AB, Helderman JH (2003) Recurrent lupus nephritis in renal transplant recipients revisited: It is not rare. Transplantation 75:651-656
57. Gibson DS, Ferris ME, Dooley MA, Huang K, Hogan SL (2003) Renal transplantation in children with lupus nephritis. Am J Kidney Dis 41:455-463
58. Lobbedez T, Comoz F, Renaudineau E, Pujo M, Ryckelynck JP, Hurault de Ligny B (2003) Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation. Am J Kidney Dis 42:E18
59. Besbas N, Ozaltin F, Tinaztepe K, Gü̧er, Ozen S, Bakkaloglu M, Bakkaloglu A (2003) Successful renal transplantation in a child with ANCA-associated microscopic polyangeitis. Pediatr Nephrol 18:696-699
60. Constantinescu AR, Liang M, Laskow DA (2002) Sirolimus lowers myeloperoxidase and p-ANCA titers in a pediatric patient before kidney transplantation. Am J Kidney Dis 40:407-410
61. Elmedhem A, Adu D, Savage COS (2003) Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant 18:1001-1004
62. van Calvar SC, Harding CO, Lyne P, Hogan K, Banerjee R, Sollinger H, Rieselbach RE, Wolff JA (1998) Renal transplantation in a patient with methylmalonic acidaemia. J Inherit Metab Dis 21:729-737
63. Salifu MO, Nicastri AD, Markell MS, Ghali H, Sommer BG, Friedman EA (2004) Allograft diabetic nephropathy may progress to end-stage renal disease. Pediatr Transplant 8:351-356
64. Kukura S, Viklicky O, Lacha J, Voska L, Honsova E, Teplan V (2004) Recurrence of sarcoidosis in renal allograft during pregnancy. Nephrol Dial Transplant 19:1640-1642
65. Brown HA (1998) Recurrence of 2,8-dihydroxyadenine tubulointerstitial lesions in a kidney transplant recipient with a primary presentation of chronic renal failure. Nephrol Dial Transplant 13:998-1000
66. Rudin C, Pritchard J, Fernando ON, Duffy P, Trompeter RS (1998) Renal transplantation in the management of bilateral Wilms' tumour and of Denys-Drash syndrome. Nephrol Dial Transplant 13:1506-1510
67. Thomas SE, Hutchinson RJ, DebRoy M, Magee JC (2004) Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Pediatr Transplant 8:507-512
68. Charytan D, Torre A, Khurana M, Nicastri A, Stillman IE, Kalluri R (2004) Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome. J Nephrol 17:431-435
69. Fonck C, Loute G, Cosyns JP, Pirson Y (1998) Recurrent fulminant anti-glomerular basement membrane nephritis at a 7-year interval. Am J Kidney Dis 32:323-327
70. Mendizabal S, Zamora I, Serrano A, Sanahuja MJ, Roman E, Dominguez C, Ortega P, Ibarra FG (2006) Renal transplantation in children with posterior urethral valves. Pediatr Nephrol 21:566-571
71. Bartsch LA, Sarwal M Orlandi P, Yorgin PD, Salvatierra Jr O (2002) Limited surgical interventions in children with posterior urethral valves can lead to better outcomes following renal transplantation. Pediatr Transplant 6:400-405
72. Roland ME, Stock PG (2003) Review of solid-organ transplantation in HIV-infected patients. Transplantation 75:425-429
73. El Sayegh S, Keller MJ, Huprikar S, Murphy B (2004) Solid organ transplantation in HIV-infected recipients. Pediatr Transplant 8:214-221
74. Vaidya S, Sellers R, Kimball P, Shanahan T, Gitomeh J, Gugliuzza K, Fish JC (2000) Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation 69:1348-1352
75. Heidenreich S, Junker R, Wolters H, Lang D, Hessing S, Nitsche G, Nowak-Göttl U (2002) Outcome of kidney transplantation in patients with inherited thrombophilia: Data of a prospective study. J Am Soc Nephrol 14:234-239
76. Schwimmer J, Nadasdy TA, Spitalnik PF, Kaplan KL, Zand MS (2003) De novo thrombotic microangiopathy in renal transplant recipients: A comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis 41:471-479
77. Reynolds JC, Agodoa LY, Yuan CM, Abbott KC (2003) Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis 42:1058-1068
78. Kowalewska J, Yuan S, Sustento-Reodica N, Nicosia RF, Smith KD, Davis CL, Alpers CE (2005) IgA nephropathy with crescents in kidney transplant recipients. Am J Kidney Dis 45:167-175
79. Robert JJ, Tête MJ, Guest G, Gagnadoux MF, Niaudet P, Broyer M (1999) Diabetes mellitus in patients with infantile cystinosis after renal transplantation. Pediatr Nephrol 13:524-529
80. Ojo A, Meier-Kriesche HU, Friedman G, Hanson J, Cibrik D, Leichtman A, Kaplan B (2000) Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation 69:2337-2339
81. Barbey F, Lidove O, Schwarting A (2008) Fabry nephropathy: 5 years of enzyme replacement therapy - a short review. NDT Plus 1:11-19
82. Ginevri F, Pastorino N, de Santis R, Fontana I, Sementa A, Losurdo G, Santopietro A, Perfumo F, Locatelli F, Maccario R, Azzi A, Comoli P (2003) Transplantation after kidney graft loss due to polyoma virus nephropathy: Successful outcome without original allograft nephrectomy. Am J Kidney Dis 42:821-825